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ABSTRACT: This work aimed to evaluate how aging could influence patients’ perception of health quality 
of life (HRQOL), as well as, the effect of aging on dialysis adequacy and in hematological, iron status, 
inflammatory and nutritional markers. In this transversal study were enrolled 305 ESRD patients under 
online-hemodiafiltration (OL-HDF) (59.67% males; 64.9 ± 14.3 years old). Data about comorbidities, 
hematological data, iron status, dialysis adequacy, nutritional and inflammatory markers were collected 
from patient’s records. Moreover, HRQOL score, by using the Kidney Disease Quality of Life-Short Form 
(KDQOL-SF), was assessed. Analyzing the results according to quartiles of age, significant differences were 
found for some parameters evaluated by the KDQOL-SF instrument, namely for work status, physical 
functioning and role-physical, which decreased with increasing age. We also found a higher proportion of 
diabetic patients, a decrease in creatinine, iron, albumin serum levels, transferrin saturation and nPCR, with 
increasing age. Moreover, significant negative correlations were found between age and mean cell 
hemoglobin concentration, iron, transferrin saturation, albumin, nPCR, work status, physical functioning 
and role-physical. In conclusion, our results showed that aging is associated with a decreased work status, 
physical functioning and role-physical, with a decreased dialysis adequacy, iron availability and nutritional 
status, and with an increased proportion of diabetic patients and of patients using central venous catheter, 
as the vascular access. The knowledge of these changes associated with aging, which have impact in the 
quality of life of the patients, could be useful in their management.  
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End-stage renal disease (ESRD) patients present high 
mortality rate [1,2] that far exceeds the mortality rate for 
the general population [3]. In the past half century, the 
widespread use of dialysis to prolong life of ESRD 
patients has been a remarkable achievement, preventing 
death from uremia in these patients. Nowadays, this 
therapy has expanded widely and is particularly used by 
an increased elderly population, leading to significant 
economic consequences to patients and to healthcare 
systems. Although some evidence may suggest that 
mortality rate among dialysis patients have decreased over 
the last few years, actually, patient’s survival is still low. 
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Cardiovascular diseases (CVD) are the most common 
cause of death in these patients [4].  
Dialysis presents a considerable negative impact on 
the functional status and in the health-related quality of 
life (HRQOL) of ESRD patients, as perceived by the 
patients. Dialysis is associated to symptoms that affect the 
daily life of the patients, and there is growing evidence 
that patients give more importance to the HRQOL than to 
survival [5]. Moreover, recent reports have shown that 
questionnaire-derived assessment of HRQOL is a strong 
and independent predictor of mortality and morbidity in 
ESRD patients [6-8]. For instance, the Dialysis Outcomes 
and Practice Patterns Study (DOPPS) concluded that a 
value lower than 10-points in Physical Component 
Summary of SF-36 was associated with a higher mortality 
risk, as compared to the risk associated to a albumin serum 
level lower than 1g/dL [9].  
Dialysis is the most important replacement therapy to 
prolong life of ESRD patients. In the last years, online 
hemodiafiltration (OL-HDF) technique has been 
introduced as an alternative to the classical hemodialysis 
(HD) procedure, which may reduce the risk of morbidity 
and mortality of ESRD patients [10,11]. In fact, a 
reduction of 30% in all-cause mortality, of 33% in 
cardiovascular mortality, and of 55% in risk of infection-
related mortality, has been described in OL-HDF patients, 
when compared with those on conventional high-flux HD 
[12]. However, other studies [13] showed similar 
morbidity and mortality risk values for both dialysis 
techniques.  
Currently, a higher proportion of dialysis patients are 
old, raising a major challenge to health care systems [14], 
as they usually show a high number of comorbidities, the 
functional status is poor, the prevalence of depression is 
high and they often avoid personal involvement [15]. 
However, there is a lack of information about the effect of 
aging in HRQOL, and in clinical and analytical 
characteristics of dialysis patients. By this reason, we 
aimed to evaluate how age could influence patients’ 
perception of HRQOL. Moreover, we also aimed to 
evaluate the effect of aging on dialysis adequacy and in 
hematological, iron status, inflammatory and nutritional 
markers.  
 
MATERIAL AND METHODS 
 
Patients and study design 
 
A descriptive transversal observational study was 
conducted to assess the HRQOL in ESRD patients on OL-
HDF, by using Kidney Disease Quality of Life-Short 
Form (KDQOL-SF) instrument, in order to study the 
impact of age on HRQOL. Patients were grouped into four 
categories based on age quartiles, the first quartile 
included patients with less than 56 years old (n = 77), the 
second quartile included patients between 57 to 68 years 
old (n = 86), the third quartile included patients between 
69 and 75 years old (n = 70), and the last quartile included 
patients with more than 75 years old (n = 72). 
This work had the collaboration of five dialysis units from 
the north of Portugal. A total of 305 patients (59.67% 
males), with a mean (±SD) age of 64.9 ± 14.3 years old, 
was evaluated. Patients were under therapeutic dialysis 
three times per week for the duration of 3-5 hours each 
session. The main causes of renal failure, in our group of 
patients, were diabetic nephropathy (n=116), 
hypertensive nephrosclerosis (n=45), other diseases or 
uncertain etiology (n=144). 
For OL-HDF procedure, Fresenius Medical Care 
dialysis machines (model 5008) and synthetic high-flux 
polysulfone dialyzers (Fresenius Medical Care, Bad 
Hamburg, Germany) were used. Patients were excluded if 
they were under 18 years old, cognitively impaired, had a 
severe speech or hearing impairment, malignancy, 
autoimmune disease, inflammatory or infectious diseases, 
and if they were in the dialysis program for less than three 
month.  
At starting the study, the patients were clinically 
evaluated and blood samples were collected for analytical 
evaluation; KDQOL-SF questionnaire was self-
administered to all patients. This survey collected data on 
age, gender, time under dialysis, etiology of kidney 
disease, hematological data, iron status, inflammatory and 
nutritional markers, as well as data on dialysis adequacy, 
from patient records. Laboratory data were obtained by 
using standard techniques. Blood was collected 
immediately before the second dialysis session of the 
week. Hematological data were accessed by using an 
automatic blood cell counter (Sysmex K1000; Sysmex, 
Germany). Differential leukocyte and reticulocyte counts 
were performed by microscopy. Serum iron concentration 
was determined using a colorimetric method (Iron, 
Randox Laboratories Ltd., North Ireland, UK), whereas 
serum ferritin and transferrin were measured by 
immunoturbidimetry (Ferritin, Laboratories Ltd., North 
Ireland, UK; Transferrin, Laboratories Ltd., North 
Ireland, UK).  Serum C-reactive protein (CRP) was 
determined by nephelometry [CRP (latex) High-
Sensitivity, Roche Diagnostics]. 
The study was approved by the Ethic Committee of 
the Institute of Health Sciences of Portuguese Catholic 
University. All patients gave written informed consent to 
participate in this study. The study was conducted in 
accordance with the Declaration of Helsinki. 
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Table 1.  Clinical data, hematological and biochemical data, nutritional markers and dialysis adequacy for total ESRD 
patients on OL-HDF, according to age (quartiles) 
 
  
ESRD patients 
1st quartile 
(< 56 years old) 
(n=77) 
  
ESRD patients 
2nd quartile 
(57-68 years old) 
(n=86) 
  
  
ESRD patients 
3rd quartile 
(69-75 years old) 
(n=70) 
  
ESRD patients 
4th quartile 
(>75 years old) 
(n=72) 
  
  
P value 
(ANOVA 
analysis) 
Clinical data, and dialysis adequacy markers 
CVC use, n (%) 14 (17.1) 18 (20.5) 11 (15.3) 26 (34.2)   
0.02# AVF use, n (%) 68 (82.9) 70 (79.5) 61 (84.7) 50 (65.8) 
Diabetic patients, n (%) 21 (25.6) 35 (39.7) 33 (45.8) 27 (35.5) 0.04# 
Hypertensive patients, n (%) 16 (19.5) 9 (10.2) 10 (13.9) 11 (14.4) 0.40# 
Previous time on dialysis, months 73.45 (153.70) 59.24 (100.67) 64.53 (139.66) 58.13 (91.28) 0.85 
URR, % 76.75 (5.08) 76.99 (5.93) 76.34 (6.64) 76.93 (7.56) 0.92 
KT/Ve 1.55 (0.34) 1.54 (0.32) 1.47 (0.25) 1.55 (0.38) 0.41 
Creatinine, mg/dL 9.16 (2.81) 7.88 (2.92) 7.14 (2.76) 6.22 (2.41) <0.001 
Darbepoeitin, μg/kg/week 0.32 (0.43) 0.41 (0.69) 0.39 (0.44) 0.36 (0.40) 0.70 
Hematological data 
Hemoglobin, g/dL 11.67 (1.46) 11.61 (1.44) 11.69 (1.20) 11.56 (1.38) 0.93 
Hematocrit, % 35.70 (4.50) 35.81 (4.37) 36.24 (3.74) 35.88 (4.31) 0.88 
Erythrocytes, x1012 /L 3.75 (0.49) 3.77 (0.54) 3.85 (0.45) 3.74 (0.52) 0.56 
MCV, fl 95.47 (5.46) 95.61 (5.87) 94.46 (5.81) 96.31 (6.10) 0.28 
MCH, pg 31.21 (2.01) 30.27 (5.05) 30.05 (4.17) 30.99 (2.14) 0.13 
MCHC, g/dL 32.69 (0.97) 32.39 (1.12) 32.26 (1.16) 32.18 (1.08) 0.20 
RDW, % 14.60 (1.50) 14.46 (1.36) 14.93 (1.49) 14.99 (1.64) 0.30 
White blood cells, x109/L 6.76 (1.95) 6.26 (1.81) 7.17 (2.78) 6.65 (2.79) 0.11 
Neutrophil/Lymphocyte ratio 2.68 (1.62) 2.98 (1.42) 2.90 (1.27) 2.84 (1.29) 0.55 
Iron status 
Iron, mg/dL 74.53 (31.99) 74.91 (33.09) 63.04 (24.52) 61.91 (23.51) 0.01 
Transferrin, mg/dL 194.26 (43.18) 209.59 (121.84) 185.62 (40.21) 204.12 (97.38) 0.31 
Transferrin saturation, % 28.94 (14.81) 30.34 (13.80) 25.23 (11.53) 24.47 (9.64) 0.01 
Ferritin, ng/mL 355.69 (213.85) 430.21 (238.55) 408.79 (267.16) 413.11 (239.42) 0.22 
Inflammatory markers 
CRP, mg/dL 6.53 (11.28) 10.02 (18.36) 13.77 (19.67) 8.72 (12.04) 0.13 
Nutritional markers 
Albumin, g/dL 45.04 (13.61) 43.59 (10.52) 41.57 (7.92) 39.37 (8.01) 0.01 
BMI, Kg/m2 24.80 (4.33) 26.46 (5.05) 26.54 (4.08) 24.82 (4.08) 0.01 
nPCR, g/kg/day 1.51 (0.75) 1.43 (0.61) 1.34 (0.62) 1.17 (0.35) 0.01 
 Results are presented as mean (SD). # chi-squared test or Fisher’s exact test. CVC: central venous catheter; AVF: arteriovenous fistula; URR: urea 
reduction ratio; MCV: mean cell volume; MCH: mean cell hemoglobin; MCHC: mean cell hemoglobin concentration; RDW: red blood cell distribution 
width; CRP: C-reactive protein; BMI: body mass index; nPCR: normalized protein catabolic rate. 
 
 
 
Kidney Disease Quality of Life Questionnaire-Short 
Form 
 
KDQOL-SF became the most widely used QOL measure 
for ESRD patients. It was developed in the United States 
of America for dialysis patients [16], and has been 
translated into several languages, to be used in several 
large studies involving dialysis patients [17-19]. In the 
present work, HRQOL was assessed with the validated 
instrument KDQOL-SF version 1.3 for Portuguese 
population [20]. This query was given to the patients at 
starting of the dialysis session, and they were helped to fill 
out the forms, if necessary. 
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The KDQOL-SF can be divided in a generic part and 
in a disease-specific part. The generic part is formed by 
the Short Form (SF-36, version 2). The SF-36 has 8 
domains: the patient’s physical functioning (10 items); 
role physical (4 items); pain (2 items); general health (5 
items), emotional well-being (5 items); role-emotional (3 
items); social functioning (2 items); and energy and 
fatigue (4 items) [20,21]. The disease-specific part of the 
KDQOL-SF consists of 43 kidney disease-targeted 
questions. The responses to these items are condensed in 
11 domains: symptom/problems (12 items), effects of 
kidney disease (8 items), burden of kidney disease (4 
items), work status (2 items), cognitive function (3 items), 
quality of social interaction (3 items), sexual function (2 
items), sleep (4 items), social support (2 items), staff 
encouragement (2 items) and patient satisfaction (1 item). 
This group of questions covers different domains to face 
the multidimensional nature of HRQOL-SF. These 
domains have a score from 0 to 100, with higher scores 
indicating a better quality of life, or the absence of 
problems.  
 
 
Table 3. HRQOL results based on the KDQOL-SF instrument for ESRD patients on OL-HDF, according 
to age (quartiles) 
 
  
ESRD patients 
1st quartile 
(< 56 years old) 
(n=77) 
ESRD patients 
2nd quartile 
(57-68 years 
old) 
(n=86) 
 ESRD patients 
3rd quartile 
(69-75 years 
old) 
(n=70) 
ESRD patients 
4th quartile 
(>75 years old) 
(n=72) 
  
 P value 
(ANOVA 
analysis) 
ESRD–targeted Areas 
Symptoms/problem list 76.68 (17.83) 76.60 (14.63) 74.35 (16.80) 76.39 (17.02) 0.81 
Effects of kidney disease 65.22 (23.33) 63.28 (21.51) 66.32 (22.04) 71.78 (15.79) 0.09 
Burden of kidney disease 29.01 (26.60) 23.22 (22.40) 26.19 (25.65) 22.86 (23.27) 0.35 
Work status 21.95 (36.09) 10.67 (26.67) 7.97 (22.07) 8.90 (22.58) 0.01 
Cognitive function 80.78 (19.38) 78.25 (16.89) 74.62 (22.04) 77.37 (22.04) 0.31 
Quality of social 
interaction 
82.81 (18.90) 83.94 (17.01) 80.99 (19.10) 77.74 (22.42) 0.20 
Sexual function 83.23 (23.15) 68.94 (30.16) 85.00 (21.23) 75.00 (34.46) 0.09 
Sleep 36.10 (13.62) 41.93 (15.30) 42.33 (16.56) 40.02 (15.29) 0.07 
Social support 77.71 (29.37) 82.01 (27.94) 82.63 (28.79) 83.56 (28.26) 0.58 
Dialysis care 
Staff encouragement 86.09 (25.78) 90.59 (17.09) 91.12 (19.66) 89.93 (19.97) 0.42 
Patient satisfaction 63.62 (24.86) 57.30 (22.47) 55.71 (24.22) 60.31 (20.90) 0.15 
36-item health survey (SF-36) 
Physical functioning 59.39 (28.70) 44.61 (29.77) 40.69 (32.21) 32.17 (26.39) <0.001 
Role-physical 36.97 (37.90) 23.37 (28.47) 20.71 (30.68) 26.40 (31.23) 0.01 
Pain 69.55 (26.34) 60.92 (29.93) 64.36 (28.39) 57.33 (33.49) 0.06 
General health 34.94 (22.48) 33.45 (21.35) 35.41 (22.86) 37.43 (20.96) 0.72 
Emotional well-being 62.80 (24.28) 61.07 (23.83) 59.08 (26.16) 63.11 (26.10) 0.75 
Role-emotional 49.14 (30.41) 43.18 (34.08) 47.89 (30.43) 42.02 (31.33) 0.42 
Energy/ Fatigue 50.73 (19.66) 47.87 (17.60) 49.30 (21.63) 45.75 (20.54) 0.45 
Social function 70.78 (33.49) 74.15 (31.93) 64.06 (36.15) 63.82 (35.51) 0.15 
 
Results are presented as mean (SD). 
 
Statistical analysis 
 
All variables are reported as mean ± standard deviation or 
as proportions. Data were analyzed using the program 
SPSS 20.0 for Windows (SPSS, Inc., Chicago, IL). The 
Normality of data was tested using the Kolmogorov-
Smirnov test. Multiple comparisons between groups were 
performed by one-way ANOVA supplemented with 
Tukey s´ HSD Post Hoc test. Differences between groups 
were analyzed by using Student t-test or Mann-Whitney 
test, according to the results obtained in the Kolmogorov-
Smirnov test.  The association between categorical 
variables was analyzed using the chi-squared test or 
Fisher’s exact test. Pearson´s rank correlation coefficient 
was used to evaluate relationships between sets of data. 
P<0.05 was accepted as statistically significant.  
 
RESULTS  
 
The socio-demographic data, clinical features, dialysis 
adequacy, biochemical and hematological data, and 
nutritional markers of ESRD patients under OL-HDF, are 
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presented in tables I and II, according to quartile of age 
and gender. The HRQOL results, based on the KDQOL-
SF instrument, are displayed in tables III and IV.  
Analyzing the results according to quartiles of age, 
when considering all patients, we found that ESRD 
patients with less than 56 years (1st quartile) presented a 
significantly lower proportion of diabetic patients, 
increasing this proportion with age. A significant decrease 
with age was observed for serum levels of creatinine, iron, 
transferrin saturation, albumin and nPCR. Concerning to 
body mass index (BMI), we also found significant 
differences between age groups, with patients in the 
second and third quartiles presenting higher BMI values 
(Table I).  
 
 
 
Table 4.  HRQOL results based on the KDQOL-SF instrument for ESRD patients on OL-HDF, according to age 
(quartiles) and gender. 
 
 
Results are presented as mean (SD).*p<0.05 vs. women. 
When we analyzed data separately, for men and 
women, we found that both presented a similar pattern, 
with decreasing levels of creatinine with age; a significant 
decrease in iron serum levels was observed only in men, 
according to age. When we compared the results for men 
and women in each age quartile, we found that men, in the 
first quartile, presented significantly higher values of 
creatinine and albumin, and a significantly lower KT/Ve; 
in the second quartile, men presented a significantly lower 
URR and KT/Ve, and, as occurred for those men in the 1st 
quartile, significantly higher values of creatinine and 
albumin; in the third quartile, men still presented 
significantly lower values of URR and KT/Ve; and, in the 
last quartile, we only found significantly lower values of 
albumin, in men (Table II). 
Concerning to HRQOL, the use of KDQOL-SF 
instrument, showed significant differences for work 
status, physical functioning and role-physical, which 
decreased with increasing age (table III), when 
considering all patients. When we analyzed the results by 
gender, we found a decrease in work status, patient 
satisfaction and role-physical, in women with more than 
56 years of age. In men, we found significant differences 
in physical functioning, decreasing with increasing age. 
When we compared the results between men and women 
in each age quartile, we found that men, in the first 
quartile, presented a significant increase in physical 
functioning and pain, and a significantly higher values of 
patient’s satisfaction; in the second quartile, men 
presented significantly higher values of 
symptoms/problem list, work status, physical functioning, 
role physical, pain and emotional well-being; in the third 
quartile, men presented significantly higher values of 
symptoms/problem list, work status, role physical, pain, 
general health, role-emotional and energy/fatigue; in the 
last quartile, men presented significantly higher values of 
symptoms/problem list, quality of social interactions and 
of pain (Table IV). 
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Figure 1. Correlations between age and MCHC, iron, transferrin saturation, albumin and nPCR in ESRD patients.  
 
 
 
Considering all ESRD patients, significant negative 
correlations were found between age and MCHC, iron, 
transferrin saturation, albumin, nPCR (Fig. 1), work status 
(r=-0.199; p<0.001), physical functioning (r=-0.323; 
p<0.001) and role-physical (r=-0.182; p=0.001).   
 
DISCUSSION 
 
The dialysis therapy in ESRD has a considerable impact 
on functional status and in the quality of life of the 
patients, as it is, usually, accompanied by symptoms that 
affect daily life. Indeed, it seems that HRQOL is more 
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important for the patient than its own survival [5]. 
Therefore, we figured as important to evaluate the 
patient s´ perception of HRQOL and to identify the 
variables that might underlie worsening of the quality of 
life of these patients [22,23]. As the prevalence of ESRD 
increases with age, we studied the perception of HRQOL 
in ESRD patients under OL-HDF therapy, according to 
age, and also according to gender. Besides the HRQOL as 
perceived by the patients, we gathered socio-demographic 
data, clinical features and several analytical studies of the 
patients. 
Our study showed that increasing age in ESRD 
patients is associated with a decrease in physical 
functioning, role-physical and work status; physical 
functioning presented a progressive decrease with age, 
while work status and role-physical decreased 
progressively from the first to the third quartile of age, and 
remained almost constant afterwards, suggesting that the 
perception of the patients about its own physical 
capacities changes after the age of 75 years, probably 
because their target pattern for physical activity becomes 
lower. A similar perception was found in women patients; 
they also presented a significant decrease in patient’s 
satisfaction, after the age of 57 years. Men‘s perception of 
HRQOL was more favorable, as only a significant 
decrease in physical functioning was found with 
increasing age. 
When we compared the HRQOL for men and women, 
in each quartile of age, men presented significantly 
increased values in several domains, some showing an 
improvement in their perception of HRQOL, namely, 
work status, quality of social interaction, physical 
functioning, general health, role emotional, and others 
reflecting a worst perception of HRQOL, as symptoms 
problem list and pain. These changes are particularly 
evident for patients 57 to 75 years old. Actually there are 
no differences between the perception of HRQOL for 
older men and women, above 75 years old.  The more 
negative disease perception of women might be associated 
with the increased prevalence of depression in women. 
Moreover, a lower social status, lower education, worst 
financial situation, or lack of employment that have been 
consistently associated with impaired HRQOL [24, 25], 
are usually more frequent in women, which could also 
contribute to the differences observed in HRQOF for men 
and women.  
Along with the decrease in physical domains of 
HRQOL with aging, we found a decrease in creatinine 
serum levels and in nutritional status. Indeed, aging is 
associated with loss of skeletal muscle mass, contributing 
to the decrease in creatinine serum levels, observed with 
aging. There are reports in literature showing that older 
dialysis patients present a higher risk of developing 
energy-protein malnutrition [26,27], which are in 
accordance with our results showing a progressive 
decrease in nutritional markers (albumin serum levels and 
nPCR), with increasing age. However, BMI did not follow 
the same pattern, as it was higher in the second and third 
quartile of age, as compared to the first and fourth 
quartiles of age. Actually, it has been reported that a 
higher BMI in ESRD patients on dialysis is paradoxically 
protective and associated with improved survival, while 
lower BMI has been associated with increased mortality 
[28-31]. These findings have been referred as a “reverse 
epidemiology”. Indeed, a high BMI is a risk factor for the 
development and progression of CKD; however, it seems 
that there are some mechanisms that protect ESRD 
patients with higher BMI, as compared to those with 
lower BMI [32,33].  
It is known that ESRD patients develop an anemia, 
which is mainly due to the incapacity of the kidneys to 
produce erythropoietin, the hormone regulator of 
erythrocyte production. The anemia is corrected by 
administration of recombinant human erythropoietin to 
achieve the target values of hemoglobin 11-12 g/dl. The 
hemoglobin concentration of these ESRD patients shows 
that most of them reached those target hemoglobin 
concentrations, and the values are similar, independently 
of age and gender.  However, concerning iron status, we 
found a significant decrease in seric iron and transferrin 
saturation, with age. The rhEPO needs to maintain 
hemoglobin values present a trend towards increasing 
values with age, in spite of the increased values of iron 
storage that could be used for erythropoiesis; moreover a 
trend towards a lower mean cell hemoglobin 
concentration, further suggests an increasing disturbance 
in iron metabolism [34]. Actually, a significant negative 
correlation was found between age and MCHC, seric iron 
and transferrin saturation, further strengthening the 
development of a disturbance in iron metabolism with 
increasing age of ESRD patients. Considering that women 
present, independently of age quartile, a lower MCHC, the 
fatigue and other associated features of anemia, might 
contribute to the more negative perception of HRQOL 
observed in women.  
A significant negative correlation was found in both, 
women and men, between age and markers of dialysis 
adequacy (urea, URR and KTVe), suggesting that aging 
is associated with a decrease in dialysis adequacy, in 
accordance with previous reports [35,36]. Dialysis 
adequacy markers are not independent variables, as they 
are influenced by protein intake and body composition. As 
already referred, ESRD patients present a weaker 
nutritional status with increasing age that may underlie the 
reduction in dialysis adequacy. Indeed, a significant 
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negative correlation was found between age and albumin 
concentration and nPCR.  
As previously reported [37-39], aging is associated 
with increased use of central venous catheter (CVC), 
particularly in women. Higher age and female gender are 
independently associated with the use of CVC rather than 
with arteriovenous fistula (AVF), at starting dialysis. The 
underlying reasons for these findings are poor clarified; 
however, there is evidence that female gender and 
advanced age are associated with shorter duration of 
primary vascular access patency [40]. Moreover, dialysis 
flow rates achieved by AVF in men seems to provide a 
greater benefit over catheters, compared with the benefit 
achieved in women, as CVC-related infections and other 
complications are more common and/or severe in men.  
We also found that aging is associated with an 
increase in the proportion of diabetic patients, which 
decreased in the last quartile of age. In fact, it is well 
known that the prevalence of diabetes increases 
significantly with age [41]. The reduction of diabetes in 
ESRD patients with more than 75 years of age is, 
probably, explained by the high mortality observed in 
diabetic ESRD patients, usually due to cardiovascular 
events [42].  
In conclusion, our data show that aging is associated 
with worsening of patient’s perception of HRQOL, 
namely, in work status, physical functioning and role-
physical, and this is particularly negative for women. 
These changes in patient’s perception was linked to a 
decrease in nutritional status that might underlie the 
reduction in dialysis adequacy, a disturbance in iron 
metabolism that seems to compromise iron availability, 
worsening anemic features and HRQOL of ESRD 
patients. The knowledge of these changes associated with 
aging, which have impact in the quality of life of the 
patients, could be useful in their management. 
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[15]  Laudański K, Nowak Z, Niemczyk S (2013). Age-
related differences in the quality of life in end-stage 
renal disease in patients enrolled in hemodialysis or 
continuous peritoneal dialysis. Med Sci Monit, 19:378-
385.  
[16]  Rebollo P, Ortega F, Baltar JM et al. (1998). Health-
related quality of life HRQOL in end stage renal disease 
ESRD patients over 65 years. Geriatr Nephrol Urol, 8: 
85–94. 
[17] Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB 
(1994). Development of the kidney disease quality of 
life (KDQOL) instrument. Qual Life Res, 3:329-338. 
[18]  Mapes DL, Bragg-Gresham JL, Bommer J, et al.  (2004). 
Health-related quality of life in the Dialysis Outcomes 
and Practice Patterns Study (DOPPS). Am J Kidney Dis, 
44(suppl 2):54-60. 
[19]  Unruh M, Benz R, Greene T, et al. (2004). Effects of 
hemodialysis dose and membrane flux on health-related 
A. Moura et al                                                                                               Effect of aging in HRQOL in OL-HDF patients 
Aging and Disease • Volume 6, Number 1, February 2015                                                                           26 
 
quality of life in the HEMO Study. Kidney Int, 66:355-
366.  
[20]  Ferreira PL, Anes EJ (2010). Medição da qualidade de 
vida de insuficientes renais crónicos: criação da versão 
portuguesa do KDQOL-SF. Rev Port Sau Pub, 28: 31-
39. 
[21]  Lessan-Pezeshki M, Zohreh Rostami (2009). 
Contributing Factors in Health-Related Quality of Life 
Assessment of ESRD Patients: A Single Center Study. 
Int  J  Nephrol  Urol, 1:129-136. 
[22]  Anees M, Hameed F, Mumtaz A, Ibrahim M, Saeed 
KhanMN (2011). Dialysis-Related Factors Affecting 
Quality of Life in Patients on Hemodialysis. Iran J 
Kidney Dis, 5:9-14. 
[23] Knight EL, Ofsthun N, Teng M, Lazarus JM, Curhan GC 
(2003). The association between mental health, physical 
function and hemodialysis mortality. Kidney Int, 
63:1843-1851.  
[24]  Simmons RG, Abress L (1990). Quality-of-life issues 
for end-stage renal disease patients. Am J Kidney Dis, 
15:201-208. 
[25]  Kalantar-Zadeh K, Fouque D, Kopple JD (2004). 
Outcome research, nutrition, and reverse epidemiology 
in maintenance dialysis patients. J Ren Nutr, 14:64-71. 
[26]  Schiffl H (2007). Prospective randomized cross-over 
long-term comparison of online haemodiafiltration and 
ultrapure high-flux haemodialysis. Eur J Med Res, 
12:26-33. 
[27]  Cuevas X, García F, Martín-Malo A, Fort J, Lladós F, 
Lozano J, Pérez-García R (2011). Risk Factors 
Associated with Cardiovascular Morbidity and 
Mortality in Spanish Incident Hemodialysis Patients: 
Two-Year Results from the ANSWER Study. Blood 
Purif, 33:21-29. 
[28]  Yen TH, Lin JL, Lin-Tan DT, Hsu CW (2010). 
Association between body mass and mortality in 
maintenance hemodialysis patients. Ther Apher Dial, 
14:400-408. 
[29]  Tanner RM, Brown TM, Muntner P (2012). 
Epidemiology of Obesity, the Metabolic Syndrome, and 
Chronic Kidney Disease. Curr Hypertens Rep, 14:152-
159. 
[30]  Kalantar-Zadeh K, Abbott KC, Salahudeen AK, 
Kilpatrick RD, Horwich TB (2005). Survival advantages 
of obesity in dialysis patients. Am J Clin Nutr, 81:543-
554. 
[31]  Kalender B, Ozdemir AC, Dervisoglu E, Ozdemir O 
(2007). Quality of life in chronic kidney disease: effects 
of treatment modality, depression, malnutrition and 
inflammation. Int J Clin Pract, 61:569-576.  
[32]  Tanner RM, Brown TM, Muntner P (2012). 
Epidemiology of Obesity, the Metabolic Syndrome, and 
Chronic Kidney Disease. Curr Hypertens Rep, 14:152-
159. 
[33]  Kalantar-Zadeh K, Abbott KC, Salahudeen AK, 
Kilpatrick RD, Horwich TB (2005). Survival advantages 
of obesity in dialysis patients. Am J Clin Nutr, 81:543-
554.  
[34]  Costa E, Fernandes J, Ribeiro S, Sereno J, Garrido P, 
Rocha-Pereira P, Coimbra S, Catarina C, Belo L, 
Bronze-da-Rocha E, Vala H, Alves R, Reis F, Santos-
Silva A (2014). Aging is Associated with Impaired 
Renal Function, INF-gamma Induced Inflammation and 
with Alterations in Iron Regulatory Proteins Gene 
Expression. Aging Dis, in press. 
[35]  Seica A, Segall L, Verzan C et al. (2009). Factors 
affecting the quality of life of haemodialysis patients 
from Romania: a multicentric study. Nephrol Dial 
Transplant, 24: 626-629. 
[36]  Mapes DL, Bragg-Gresham JL, Bommer J, et al.  (2004). 
Health-related quality of life in the Dialysis Outcomes 
and Practice Patterns Study (DOPPS). Am J Kidney Dis, 
44(suppl 2):54-60. 
[37]  Astor BC, Coresh J, Powe NR, Eustace JA, Klag MJ 
(2000). Relation between gender and vascular access 
complications in hemodialysis patients. Am J Kidney 
Dis, 36: 1126-1134. 
[38]  Stehman-Breen CO, Sherrard DJ, Gillen D, Caps M 
(2000). Determinants of type and timing of initial 
permanent hemodialysis vascular access. Kidney Int, 57: 
639 –645. 
[39] Astor BC, Eustace JA, Powe NR, Klag MJ, Sadler JH, 
Fink NE, Coresh J (2001). Timing of nephrologist 
referral and arteriovenous access use. The CHOICE 
Study. Am J Kidney Dis, 38:494-501. 
[40] Ng YY, Wu SC, Hung YN, Ko PJ (2009). Effect of 
demographic characteristics and timing of vascular 
access maturation on patency in Chinese incident 
haemodialysis patients. Nephrol Dial Transplant, 
11:3447-3453. 
[41]  van Blijderveen JC, Straus SM, Zietse R, Stricker BH, 
Sturkenboom MC, Verhamme KM (2013). A 
population-based study on the prevalence and incidence 
of chronic kidney disease in the Netherlands. Int Urol 
Nephrol, 46:583-592 
[42]  Shoji T, Emoto M, Shinohara K, Kakiya R, Tsujimoto 
Y, Kishimoto H, Ishimura E, Tabata T, Nishizawa Y 
(2001). Diabetes mellitus, aortic stiffness, and 
cardiovascular mortality in end-stage renal disease. J 
Am Soc Nephrol, 12:2117-2124. 
